Teva Sues BioMarin In UK Over Genetic Disorder Drug Patent
Teva Pharmaceuticals has asked a London court to invalidate biotech firm BioMarin's U.K. patent on the world's only medical treatment for a rare inherited disorder affecting children as it seeks to...To view the full article, register now.
Already a subscriber? Click here to view full article